Moxifloxacin hydroc
Ended Awarded Last action
- Contract number
- SPE2DP26F0489
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,968
Award facts
- Contract value 100% obligated
- $3,967.80 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $3,967.80, awards moxifloxacin hydrochloride to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award was issued on October 29, 2025, by the Defense Logistics Agency's Medical Supply Chain division with firm fixed-price terms and no set-aside designation, indicating the contractor won on a competitive basis. The contract specifies performance at DMS Pharmaceutical Group's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. This structure enables the Defense Logistics Agency to issue multiple delivery orders for pharmaceutical products, including prescription medications, biologics, and medical consumables, to support Department of Defense military healthcare operations globally. The current delivery order for moxifloxacin hydrochloride—a fluoroquinolone antibiotic—represents routine pharmaceutical procurement to meet recurring medical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DP26F0489?
SPE2DP26F0489 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 29, 2025.
How much is contract SPE2DP26F0489 worth?
The government has obligated $3,968 on SPE2DP26F0489.
Is contract SPE2DP26F0489 an order under another contract?
Yes. SPE2DP26F0489 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F0489 competed?
The extent of competition for SPE2DP26F0489 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award